Apr 3, 2014
TapImmune Inc. (OTCQB: TPIV), A clinical stage immunother...
Mar 20, 2014
New Technology Significantly Enhances the Presentation of...
Email Sign Up
In The Media [+]

TapImmune will provide the latest stories as the media reports our progress.

BioMedReports
TapImmune CEO appears on BioMeds reports
BioMedReports
TapImmune's Key Milestone
www.pharma-mag.com
Tap: Novel Targets For Cancer Vaccine Development
CP Reports
Investor Alert - TapImmune Feature Article in CP Reports by Gene Marcial (AOL Finance and Wall St Insider) March 2011

DOTmed® news
Elegantly Simple Cancer and Infectious Disease Vaccine Uniquely Addresses Problems Found with Earlier Immunotherapy Approaches

KOMOnews.com
TapImmune, Fred Hutchinson Center get boosts for cancer treatments

Scientist Live
Immunotherapy innovation spurs 'remarkably aggressive immune response'

 

NEWS-Line
'Elegantly Simple' Cancer and Infectious Disease Vaccine

BusinessWeek
Developments to Watch:
Waking Up a Sleeping Anticancer Gene

Popular Mechanics - Attacking Cancer With an Immune-Boosting Vaccine
ABC - Business Now